109 related articles for article (PubMed ID: 9789740)
1. Structural studies of HIV-1 protease-inhibiting antibodies.
Lescar J; Stouracova R; Riottot MM; Chitarra V; Brynda J; Fabry M; Horejsi M; Sedlacek J; Bentley GA
Gen Physiol Biophys; 1998 Jun; 17 Suppl 1():3-6. PubMed ID: 9789740
[No Abstract] [Full Text] [Related]
2. Anti-HIV proteinase monoclonal antibody F11.2.32 that inhibits enzyme activity.
Stouracova R; Lescar J; Brynda J; Riottot MM; Chitarra V; Fabry M; Horejsi M; Rezacova P; Bentley G; Sedlacek J
Gen Physiol Biophys; 1998 Jun; 17 Suppl 1():6-8. PubMed ID: 9789741
[No Abstract] [Full Text] [Related]
3. Preliminary crystallographic studies of an anti-HIV-1 protease antibody that inhibits enzyme activity.
Lescar J; Stouracova R; Riottot MM; Chitarra V; Brynda J; Fabry M; Horejsi M; Sedlacek J; Bentley GA
Protein Sci; 1996 May; 5(5):966-8. PubMed ID: 8732768
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of HIV protease by monoclonal antibodies.
Rezacova P; Brynda J; Fabry M; Horejsi M; Stouracova R; Lescar J; Chitarra V; Riottot MM; Sedlacek J; Bentley GA
J Mol Recognit; 2002; 15(5):272-6. PubMed ID: 12447903
[TBL] [Abstract][Full Text] [Related]
5. Peptidomimetic inhibitors complexed with HIV-1 protease: crystallisation for X-ray diffraction studies.
Dohnálek J; Hasek J; Brynda J; Fábry M; Sedlácek J; Konvalinka J; Hradilek M; Soucek M; Adams MJ; Naylor CE
Gen Physiol Biophys; 1998 Jun; 17 Suppl 1():9-11. PubMed ID: 9789742
[No Abstract] [Full Text] [Related]
6. Crystal structure of a cross-reaction complex between an anti-HIV-1 protease antibody and an HIV-2 protease peptide.
Rezacova P; Brynda J; Lescar J; Fabry M; Horejsi M; Sieglova I; Sedlacek J; Bentley GA
J Struct Biol; 2005 Mar; 149(3):332-7. PubMed ID: 15721587
[TBL] [Abstract][Full Text] [Related]
7. X-ray structure and conformational dynamics of the HIV-1 protease in complex with the inhibitor SDZ283-910: agreement of time-resolved spectroscopy and molecular dynamics simulations.
Ringhofer S; Kallen J; Dutzler R; Billich A; Visser AJ; Scholz D; Steinhauser O; Schreiber H; Auer M; Kungl AJ
J Mol Biol; 1999 Mar; 286(4):1147-59. PubMed ID: 10047488
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, evaluation, and crystallographic-based structural studies of HIV-1 protease inhibitors with reduced response to the V82A mutation.
Clemente JC; Robbins A; Graña P; Paleo MR; Correa JF; Villaverde MC; Sardina FJ; Govindasamy L; Agbandje-McKenna M; McKenna R; Dunn BM; Sussman F
J Med Chem; 2008 Feb; 51(4):852-60. PubMed ID: 18215016
[TBL] [Abstract][Full Text] [Related]
9. Structural studies of human HIV-1 V3 antibodies.
Stanfield RL; Wilson IA
Hum Antibodies; 2005; 14(3-4):73-80. PubMed ID: 16720977
[TBL] [Abstract][Full Text] [Related]
10. Monitoring inhibitor-induced conformational population shifts in HIV-1 protease by pulsed EPR spectroscopy.
Blackburn ME; Veloro AM; Fanucci GE
Biochemistry; 2009 Sep; 48(37):8765-7. PubMed ID: 19691291
[TBL] [Abstract][Full Text] [Related]
11. Fine characterization of the antigenic site within the flap region in the protease protein of HIV-1.
Ehnlund M; Björling E
Arch Virol; 2000; 145(2):365-9. PubMed ID: 10752558
[TBL] [Abstract][Full Text] [Related]
12. Active site binding modes of curcumin in HIV-1 protease and integrase.
Vajragupta O; Boonchoong P; Morris GM; Olson AJ
Bioorg Med Chem Lett; 2005 Jul; 15(14):3364-8. PubMed ID: 15950462
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of the HIV-1 resistance development: enzymatic activities, crystal structures, and thermodynamics of nelfinavir-resistant HIV protease mutants.
Kozísek M; Bray J; Rezácová P; Sasková K; Brynda J; Pokorná J; Mammano F; Rulísek L; Konvalinka J
J Mol Biol; 2007 Dec; 374(4):1005-16. PubMed ID: 17977555
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the HIV-1 and HIV-2 proteases by a monoclonal antibody.
Lescar J; Brynda J; Rezacova P; Stouracova R; Riottot MM; Chitarra V; Fabry M; Horejsi M; Sedlacek J; Bentley GA
Protein Sci; 1999 Dec; 8(12):2686-96. PubMed ID: 10631984
[TBL] [Abstract][Full Text] [Related]
15. On the role of the R configuration of the reaction-intermediate isostere in HIV-1 protease-inhibitor binding: X-ray structure at 2.0 A resolution.
Dusková J; Dohnálek J; Skálová T; Petroková H; Vondrácková E; Hradílek M; Konvalinka J; Soucek M; Brynda J; Fábry M; Sedlácek J; Hasek J
Acta Crystallogr D Biol Crystallogr; 2006 May; 62(Pt 5):489-97. PubMed ID: 16627941
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the substrate envelope hypothesis for inhibitors of HIV-1 protease.
Chellappan S; Kairys V; Fernandes MX; Schiffer C; Gilson MK
Proteins; 2007 Aug; 68(2):561-7. PubMed ID: 17474129
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of chemically synthesized HIV-1 protease and a ketomethylene isostere inhibitor based on the p2/NC cleavage site.
Torbeev VY; Mandal K; Terechko VA; Kent SB
Bioorg Med Chem Lett; 2008 Aug; 18(16):4554-7. PubMed ID: 18657969
[TBL] [Abstract][Full Text] [Related]
18. Inorganic polyhedral metallacarborane inhibitors of HIV protease: a new approach to overcoming antiviral resistance.
Kozísek M; Cígler P; Lepsík M; Fanfrlík J; Rezácová P; Brynda J; Pokorná J; Plesek J; Grüner B; Grantz Sasková K; Václavíková J; Král V; Konvalinka J
J Med Chem; 2008 Aug; 51(15):4839-43. PubMed ID: 18598016
[TBL] [Abstract][Full Text] [Related]
19. Structural basis of HIV-1 and HIV-2 protease inhibition by a monoclonal antibody.
Rezacova P; Lescar J; Brynda J; Fabry M; Horejsi M; Sedlacek J; Bentley GA
Structure; 2001 Oct; 9(10):887-95. PubMed ID: 11591344
[TBL] [Abstract][Full Text] [Related]
20. Rapid X-ray diffraction analysis of HIV-1 protease-inhibitor complexes: inhibitor exchange in single crystals of the bound enzyme.
Munshi S; Chen Z; Li Y; Olsen DB; Fraley ME; Hungate RW; Kuo LC
Acta Crystallogr D Biol Crystallogr; 1998 Sep; 54(Pt 5):1053-60. PubMed ID: 9757136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
